Dolan Sondhi - 27 Jul 2023 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
Director
Signature
/s/ Edgar Cale, Attorney-in-Fact
Issuer symbol
PASG
Transactions as of
27 Jul 2023
Net transactions value
$0
Form type
4
Filing time
31 Jul 2023, 17:34:07 UTC
Next filing
31 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Director Stock Option (right to buy) Award $0 +48,000 $0.000000 48,000 27 Jul 2023 Common Stock 48,000 $0.8480 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 1/36 of the total shares on August 28, 2023, and thereafter vests as to 1/36 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.